Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New York Startup, Genetic Ink, Partners with Swiss Artist to Create Art from Your DNA
  • USA - English


News provided by

Genetic Ink

Mar 18, 2014, 08:00 ET

Share this article

Share toX

Share this article

Share toX

DNA Art Installation - Manhattan
DNA Art Installation - Manhattan

New York, NY (PRWEB) March 18, 2014 -- After a year of research and development, former neuroscience researcher, Kishan Bhoopalam, now CEO of Genetic Ink, announces the release of DNA Art, the first product to create fine art from human and animal DNA. The company's engineers partnered with Swiss-Canadian artist and designer Mathieu Daudelin to create Spark, an Art Style that expresses the nuances found in an individual's DNA. The final product is a beautiful, heavy-canvas, giclée fine-art print ready for home or gallery.

Genetic Ink's ambitions are profound - to not merely create something attractive, but to deliver on the very promise of art itself. DNA Art strives to express the very essence of humanity.

Post this

Bhoopalam says, "People don't realize it, but we're entering the genetic era. DNA sequencing isn't a billion dollar experiment anymore. It's not just for diagnostics either. Finally, the technology is affordable, simple and nonintrusive enough that we can use it to express and share our unique beauty."

Genetic Ink is not the first company to offer DNA Art. For many years, others have offered enlarged, dyed copies of DNA electrophoresis gels, the same ones found in many high-school biology labs. Electrophoresis does not actually sequence DNA, but only nominally represents it. However, Genetic Ink's goal is not to merely render attractive designs from DNA, but to create true art from the actual DNA sequence, a previously cost-prohibitive endeavor. This requires collaboration with artists, whose concepts, shapes, colors and relations are then turned into generative algorithms that morph to express the nuances of their subjects' DNA.

Last year, technology industry veteran, Alex Pyatetsky, came on board as Senior Advisor to the company.

"Many technology companies take on obvious, low-hanging challenges. Despite impressive engineering, the unwillingness to tackle deeper, murkier, qualitative challenges is undeniable. Genetic Ink's ambitions are profound - to not merely create something attractive, but to deliver on the very promise of art itself. DNA Art strives to express the very essence of humanity."

Mathieu Daudelin, the Swiss-Canadian artist and designer responsible for collaborating on Spark, the company's first Art Style, agrees.

"This team understands the difference between art and its descriptive decomposition. DNA data is simply a text file. This raw source does not transmit feelings of beauty, wonder, or inspiration. It is up to the artist to give meaning to that data and let the audience respond to this interpretation. That is why Genetic Ink's DNA Art focuses on art, not merely data visualization. And by doing so, they create a meaningful impact on art, as well as technology."

The Spark Art Style will be available in 4 sizes, ranging from 12" x 16" to 36" x 48", with prices starting at $200. Each piece of DNA Art includes a cotton cheek swab DNA collection kit, also designed by Daudelin, which works for adults, children, and pets. The kit is returned to Genetic Ink's CLIA-certified lab, where it undergoes fully anonymized sequencing. That sequence is fed into the Spark Art Style algorithm, and the resulting DNA Art is printed onto heavy, gallery-quality canvas.

Genetic Ink launches Spark, its first DNA Art offering, March 2014. Art and science enthusiasts are invited to sign up for the announcement at GeneticInk.com.

About Genetic Ink

Genetic Ink is the art meets science company. They collaborate with leading artists and engineers to create unique fine art from biological data. Genetic Ink seeks to inspire awe and wonder of the natural world by illuminating it through the lenses of art and science.

Genetic Ink is the first company to create true DNA Art, artist-driven, gallery-quality art from sequenced human and animal DNA.

About Kishan Bhoopalam - CEO

Kishan Bhoopalam is an Indian-American biotechnology entrepreneur and CEO of Genetic Ink. Bhoopalam was previously a neuroscience researcher and co-founded a nutraceutical venture.

About Mathieu Daudelin – Collaborating Artist, Spark

Mathieu Daudelin is a Swiss-Canadian artist and designer and graduate of l'Ecole cantonale d'art de Lausanne. His creative aspirations are to better understand the world around him.

His work explores visual language and manipulation of different materials to express ideas. It focuses on the creative process, deriving as much meaning from experimentation and exploration as from the final product itself.

About Alex Pyatetsky – Senior Advisor

Alex Pyatetsky is a serial entrepreneur and cofounder of The HOTH Corp., acquired by Next Net Media in 2013. He is a speaker on subjects ranging from growth, user experience and startup M&A. He advises startups in verticals ranging from real estate, entertainment and biotechnology.

*** For further media inquiries, please contact press(at)geneticink(dot)com. ***

Alex Pyatetsky, Genetic Ink, http://www.geneticink.com, +1 3129700637, [email protected]

Modal title

Genetic Ink Logo
Genetic Ink Logo
Swiss-Canadian Artist and Design, Mathieu Daudelin
Swiss-Canadian Artist and Design, Mathieu Daudelin
Former genetics researcher, Kishan Bhoopalam, CEO & Founder of Genetic Ink
Former genetics researcher, Kishan Bhoopalam, CEO & Founder of Genetic Ink
Genetic Ink's DNA Art Creation Process
Genetic Ink's DNA Art Creation Process
Genetic Ink's DNA Collection Kit, Designed by Mathieu Daudelin
Genetic Ink's DNA Collection Kit, Designed by Mathieu Daudelin
Genetic Ink's DNA Collection Kit features a painless cheek swab.
Genetic Ink's DNA Collection Kit features a painless cheek swab.
Close Up - Each Piece of DNA Art Signed by Collaborating Artist Mathieu Daudelin
Close Up - Each Piece of DNA Art Signed by Collaborating Artist Mathieu Daudelin
Close Up - DNA Art fine art printed on heavy, gallery-quality canvas.
Close Up - DNA Art fine art printed on heavy, gallery-quality canvas.
DNA Art Installation - Restaurant "Martha" in Brooklyn
DNA Art Installation - Restaurant "Martha" in Brooklyn
DNA Art Installation - Office of Mike Germano, Chief Digital Office, Vice
DNA Art Installation - Office of Mike Germano, Chief Digital Office, Vice
Genetic Ink Logo Swiss-Canadian Artist and Design, Mathieu Daudelin Former genetics researcher, Kishan Bhoopalam, CEO & Founder of Genetic Ink Genetic Ink's DNA Art Creation Process Genetic Ink's DNA Collection Kit, Designed by Mathieu Daudelin Genetic Ink's DNA Collection Kit features a painless cheek swab. Close Up - Each Piece of DNA Art Signed by Collaborating Artist Mathieu Daudelin Close Up - DNA Art fine art printed on heavy, gallery-quality canvas. DNA Art Installation - Restaurant "Martha" in Brooklyn DNA Art Installation - Office of Mike Germano, Chief Digital Office, Vice

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.